Table 3: Anthropometry and clinical characteristics of patients enrolled in the Indian Phenotype Registry19.
| Total population (N=37,927) | |||
|---|---|---|---|
| Variables | Males | Females | Total |
| Anthropometric measure | |||
| BMI, kg/m2 Range | 27.0 (4.3) 12.2, 54.4 |
28.0 (4.9) 11.3, 55.0 |
27.0 (4.6) 11.3, 55.0 |
| Body fat percentage, % Range | 29.0 (7.0) 2.0, 68.0 |
35.0 (7.8) 2.0, 70.0 |
32.0 (8.0) 2.0, 70.0 |
| Body weight, kg Range | 74.0 (12.9) 45.0, 148.0 |
69.0 (12.4) 45.0, 134.7 |
72.0 (13.0) 45.0, 148.0 |
| Height, cm Range | 166.4 (7.3) 137.0, 200.0 |
155.4 (7.2) 135.0, 198.0 |
161.5 (9.1) 135.0, 200.0 |
| Visceral fat percentage, % Range | 14.0 (6.3) 2.0, 58.0 |
13.0 (6.8) 2.0, 64.4 |
13.0 (6.5) 2.0, 64.4 |
| Waist circumference, cm Range | 95.2 (10.2) 60.0, 130.0 |
95.2 (10.8) 60.0, 130.0 |
95.2 (10.5) 60.0, 130.0 |
| Hip circumference, cm Range | 99.1 (9.2) 80.0, 140.0 |
102.3 (11.0) 80.0, 140.0 |
100.5 (10.2) 80.0, 140.0 |
| BMI category, n (%)a | |||
| Underweight | 467 (2.2) | 577 (3.4) | 1,044 (2.7) |
| Normal | 3,150 (14.9) | 1,905 (11.3) | 5,055 (13.3) |
| Overweight | 3,630 (17.2) | 2,221 (13.2) | 5,851 (15.4) |
| Pre-obese | 9,558 (45.2) | 6,949 (41.3) | 16,508 (43.5) |
| Obese Obese type 1 Obese type 2 Obese type 3 |
4,293 (20.3) 4,094 (95.3) 192 (4.4) 7 (0.2) |
5,175 (30.7) 4,822 (93.5) 342 (6.6) 11 (0.2) |
9,469 (25.0) 8,917 (94.1) 534 (5.6) 18 (0.2) |
| Vital signs, mean (SD) | |||
| SBP, mmHg Range | 131.3 (14.8) 80.0, 200.0 |
131.2 (15.3) 80.0, 200.0 |
131.3 (15.0) 80.0, 200.0 |
| DBP, mmHg Range | 81.4 (8.4) 50.0, 142.0 |
80.8 (8.3) 50.0, 160.0 |
81.1 (8.4) 50.0, 160.0 |
| Heart rate, beats/minute Range | 81.4 (9.6) 50.0, 130.0 |
82.0 (9.9) 50.0, 130.0 |
81.7 (9.8) 50.0, 130.0 |
| Diabetes-related measure | |||
| HbA1c, % Range | 8.3 (1.7) 5.5, 14.0 |
8.3 (1.7) 5.5, 14.0 |
8.3 (1.7) 5.5, 14.0 |
| Duration of diabetes, n (%) | |||
| <5 years | 10,071 (47.7) | 7,845 (46.6) | 17,916 (47.2) |
| 5–10 years | 7,168 (33.9) | 6,068 (36.1) | 13,236 (34.9) |
| >10–20 years | 3,152 (14.9) | 2,518 (14.9) | 5,670 (14.9) |
| >20 years | 707 (3.3) | 396 (2.3) | 1,103 (2.9) |
| On-going anti-diabetic therapy, n (%) | |||
| Yes | 20,873 (98.9) | 16,661 (99.0) | 37,536 (99.0) |
| No | 225 (1.1) | 166 (1.0) | 391 (1.0) |
Missing variables including data excluded due to erroneous or extreme values from the original sample: BMI (n=745), body fat percentage (n=746), body weight (n=696), height (n=1,515), visceral fat percentage (n=809), waist circumference (n=9,436), hip circumference (n=9,853), systolic blood pressure (n=1,617), diastolic blood pressure (n=1,619), heart rate (n=1,879), duration of diabetes (n=2) and HbA1c (n=2).
BMI categories (kg/m2): underweight = <18.5; normal = 18.5–22.9; overweight = 23.0–24.9; pre-obese = 25.0–29.9; and obese = ≥30.0.
Obese type 1 (obese), BMI = 30.0–40.0 kg/m2; obese type 2 (morbidly obese), BMI = 40.1–50.0 kg /m2; obese type 3 (super obese), BMI = >50.0 kg/m2.
aBMI category is based on ‘Asian criteria’.19
BMI = body mass index; DBP = diastolic blood pressure; HbA1c = glycated haemoglobin; SBP =systolic blood pressure; SD = standard deviation.